The Relationship Between Upper Extremity Explosive Power and Trunk Muscles in Volleyball Players

October 12, 2023 updated by: Aynur Demirel, Hacettepe University

Voleybolcularda Üst Ekstremite Patlayıcı Güç Ile Gövde Kaslarının Arasındaki İlişkinin İncelenmesi

Volleyball is an interval sport involving consecutive aerobic and anaerobic loads. Strength training based on explosive movements can improve performance in the upper extremities. Strength performance has an important place in this sport. Trunk stabilization is defined as 'proximal stability for distal mobility'. Disorder in any segment of the kinetic chain model will affect the quality of movement in the lower and upper segments.The aim of this study is to examine the relationship between the morphological features of the transversus abdominis, lumbal multifidus (L4-5), internal external oblique muscles, and the anaerobic power of the upper extremity and shoulder girdle functionThis study was designed as a cross-sectional. They will consist of 30 volleyball players between 14-30 years of age. Muscle morphological features of the participants by ultrasound; explosive strength will be evaluated by Medicine Ball Throw test, functional evaluation will be evaluated by Closed Kinetic Chain Upper Extremity Endurance test.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Ankara, Turkey, 06100
        • Aynur Demirel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Hacettepe University will be directed from the referred athletes

Description

Inclusion Criteria:

  • Training for an hour at least 3 days a week for at least 1 year
  • Body Mass Index (BMI) below 30 kg/m2
  • No concomitant neurological, rheumatological or systemic disease
  • Volunteer to participate in the study.

Exclusion Criteria:

  • Having any surgery / serious pathology of the spinal column
  • Having had an upper extremity injury in the last 6 months that would affect his ability to play volleyball
  • Having an injury that requires at least 2 weeks of discontinuation
  • Severe musculoskeletal/systemic discomfort during the measurements.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle morphology
Time Frame: 1 day
Morphological characteristics transverse abdominis, lumbar multifidus,internal obliquus, external obliquus will be evaluated via ultrasound imaging
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Expolsive Power
Time Frame: 1 day
Medicine Ball Throw
1 day
Core stability
Time Frame: 1 day
Sharmannn's Core Stability Test
1 day
Upper Extremity Endurance
Time Frame: 1 day
Closed Kinetic Chain Upper Extremity Stability Test
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aynur Demirel, PhD, HACETTEPE UNIVERSİTY

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 26, 2023

Primary Completion (Estimated)

August 26, 2025

Study Completion (Estimated)

August 26, 2025

Study Registration Dates

First Submitted

August 14, 2023

First Submitted That Met QC Criteria

August 18, 2023

First Posted (Actual)

August 21, 2023

Study Record Updates

Last Update Posted (Actual)

October 13, 2023

Last Update Submitted That Met QC Criteria

October 12, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • GO 23/540

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ultrasonography

3
Subscribe